NCT05402618 is a clinical trial of No intervention in Perihilar Cholangiocarcinoma, sponsored by Renyi Qin.

Who is sponsoring NCT05402618?

NCT05402618 is sponsored by Renyi Qin.

What drugs are being tested in NCT05402618?

Interventions in NCT05402618: No intervention.

What condition does NCT05402618 study?

NCT05402618 studies Perihilar Cholangiocarcinoma.

Is NCT05402618 still recruiting?

NCT05402618 is currently completed. Last updated 2 June 2022.

Last reviewed 2022-06-02 · How we verify

NCT05402618

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Minimally Invasive Versus Open Surgery for PHC

Completed Last updated 2 June 2022

What this trial tests

trial testing No intervention in Perihilar Cholangiocarcinoma in 783 participants. Completed in 1 April 2022.

Timeline

1 May 2018

Primary endpoint
1 January 2019

1 April 2022

Quick facts

Lead sponsor	Renyi Qin
Status	Completed
Study type	OBSERVATIONAL
Enrollment	783
Start date	1 May 2018
Primary completion	1 January 2019
Estimated completion	1 April 2022
Sites	1 location across China

Drugs / interventions tested

No intervention

Conditions studied

Perihilar Cholangiocarcinoma — all drugs for Perihilar Cholangiocarcinoma →

Sponsor

Renyi Qin

Who can join

Eligibility, any sex, with Perihilar Cholangiocarcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Summary: This is a multicentric, retrospective, real-world study to investigate the surgical outcomes of minimally invasive surgery compared with open surgery for Perihilar Cholangiocarcinoma (PHC), with the perioperative characteristics and long-term overall survival being compared. We aimed to find out whether the minimally invasive surgery is safe or feasible for PHC. And we also want to find out patients with what kind of characteristic can be benefit from the minimally invasive surgery compared with the open approach.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Laparoscopic versus open surgery for perihilar cholangiocarcinoma: a multicenter propensity score analysis of short- term outcomes.
Wang M, Qin T, Zhang H, Li J, et al · · 2023 · cited 9× · PMID 37138243 · DOI 10.1186/s12885-023-10783-9

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Perihilar Cholangiocarcinoma

Currently open trials in the same condition.

NCT06986486 — Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma · recruiting
NCT06720883 — Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study · recruiting
NCT06125769 — LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) · NA · recruiting
NCT05430698 — PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma · Phase 2 · recruiting
NCT04993131 — Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05402618 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Renyi Qin
Last refreshed: 2 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05402618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing